Rani Therapeutics Holdings, Inc. - Class A Common Stock — Quarterly Cash Flow (NASDAQ:RANI) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 36.63 M24.13 M16.9 M10.14 M58.62 M51.88 M Total liabilities 33.14 M29.47 M26.05 M22.11 M17.11 M16.34 M Total equity 3.49 M-5.35 M-9.15 M-11.97 M41.51 M35.54 M Total liabilities & shareholders' equities 36.63 M24.13 M16.9 M10.14 M58.62 M51.88 M Total debt 9.61 M5.92 M17.23 M13.54 M0— Net debt 9.61 M5.92 M-7.99 M-4.14 M-18.62 M—

News

Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript

Rani Therapeutics promotes Alireza Javadi to chief technical officer

Rani Therapeutics begins phase 1 trial of oral obesity treatment

Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement

Rani Therapeutics announces $1.085 billion Chugai collaboration

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%

Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27

Rani Therapeutics director Imran Mir a buys $1.26 million in stock

Rani Therapeutics appoints new directors and closes private placement

Rani Therapeutics adds two biotech investors to board of directors

Rani Therapeutics closes $60.3 million private placement

South Cone investments sells Rani Therapeutics (RANI) shares for $15.7m